These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33856249)

  • 21. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
    Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global loss of myelin water over 5 years in multiple sclerosis normal-appearing white matter.
    Vavasour IM; Huijskens SC; Li DK; Traboulsee AL; Mädler B; Kolind SH; Rauscher A; Moore GW; MacKay AL; Laule C
    Mult Scler; 2018 Oct; 24(12):1557-1568. PubMed ID: 28782447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation between Parkinson's Disease and the Parkinsonian Subtype of Multiple System Atrophy Using the Magnetic Resonance T1w/T2w Ratio in the Middle Cerebellar Peduncle.
    Wang J; Sugiyama A; Yokota H; Hirano S; Yamamoto T; Yamanaka Y; Araki N; Ito S; Paul F; Kuwabara S
    Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38248077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of cortical grey matter thickness reduction in multiple sclerosis.
    Fujimori J; Fujihara K; Wattjes M; Nakashima I
    Brain Behav; 2021 Apr; 11(4):e02050. PubMed ID: 33506628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.
    Ingrisch M; Sourbron S; Herberich S; Schneider MJ; Kümpfel T; Hohlfeld R; Reiser MF; Ertl-Wagner B
    Invest Radiol; 2017 Mar; 52(3):135-141. PubMed ID: 27548346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic efficacy of the magnetic resonance T1w/T2w ratio for the middle cerebellar peduncle in multiple system atrophy and spinocerebellar ataxia: A preliminary study.
    Wang J; Sugiyama A; Yokota H; Hirano S; Cooper G; Mukai H; Ohira K; Koide K; Ito S; Finke C; Brandt AU; Paul F; Kuwabara S
    PLoS One; 2022; 17(4):e0267024. PubMed ID: 35427382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimodal MRI Response to Fingolimod in Multiple Sclerosis: A Nonrandomized, Single Arm, Observational Study.
    Bernitsas E; Kopinsky H; Lichtman-Mikol S; Razmjou S; Santiago-Martinez C; Yarraguntla K; Bao F
    J Neuroimaging; 2021 Mar; 31(2):379-387. PubMed ID: 33368776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures.
    Zivadinov R; Bergsland N; Hagemeier J; Carl E; Kolb H; Hojnacki D; Weinstock-Guttman B
    J Neurol Sci; 2018 May; 388():175-181. PubMed ID: 29627017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-lesional cerebellar damage in patients with clinically isolated syndrome: DTI measures predict
    Kugler AV; Deppe M
    Neuroimage Clin; 2018; 19():633-639. PubMed ID: 29984171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple sclerosis iron rim lesions are linked to impaired cervical spinal cord integrity using the T1/T2-weighted ratio.
    Wenzel N; Wittayer M; Weber CE; Platten M; Gass A; Eisele P
    J Neuroimaging; 2023 Mar; 33(2):240-246. PubMed ID: 36504270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.
    Zivadinov R; Bergsland N; Hagemeier J; Tavazzi E; Ramasamy DP; Durfee J; Cherneva M; Carl E; Carl J; Kolb C; Hojnacki D; Weinstock-Guttman B
    J Neurol Sci; 2018 Apr; 387():152-156. PubMed ID: 29571854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T2 Relaxometry Evidence of Microstructural Changes in Diffusely Abnormal White Matter in Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome: Impact on Visuomotor Performance.
    Papadaki E; Mastorodemos V; Panou T; Pouli S; Spyridaki E; Kavroulakis E; Kalaitzakis G; Maris TG; Simos P
    J Magn Reson Imaging; 2021 Oct; 54(4):1077-1087. PubMed ID: 33960066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparameter MRI quantification of microstructural tissue alterations in multiple sclerosis.
    Lommers E; Simon J; Reuter G; Delrue G; Dive D; Degueldre C; Balteau E; Phillips C; Maquet P
    Neuroimage Clin; 2019; 23():101879. PubMed ID: 31176293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study.
    Saraste M; Bezukladova S; Sucksdorff M; Saunavaara V; Rissanen E; Matilainen M; Airas L
    Mult Scler Relat Disord; 2021 Feb; 48():102690. PubMed ID: 33352357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myelin Measurement Using Quantitative Magnetic Resonance Imaging: A Correlation Study Comparing Various Imaging Techniques in Patients with Multiple Sclerosis.
    Saccenti L; Hagiwara A; Andica C; Yokoyama K; Fujita S; Kato S; Maekawa T; Kamagata K; Le Berre A; Hori M; Wada A; Tateishi U; Hattori N; Aoki S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32046340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
    Lund H; Krakauer M; Skimminge A; Sellebjerg F; Garde E; Siebner HR; Paulson OB; Hesse D; Hanson LG
    PLoS One; 2013; 8(2):e56375. PubMed ID: 23441184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myelin content changes in Clinically Isolated Syndrome and Relapsing- Remitting Multiple Sclerosis: Associations with lesion type and severity of visuomotor impairment.
    Panou Τ; Kavroulakis E; Mastorodemos V; Pouli S; Kalaitzakis G; Spyridaki E; Maris TG; Simos P; Papadaki E
    Mult Scler Relat Disord; 2021 Sep; 54():103108. PubMed ID: 34198031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axonal damage in the optic radiation assessed by white matter tract integrity metrics is associated with retinal thinning in multiple sclerosis.
    Ngamsombat C; Tian Q; Fan Q; Russo A; Machado N; Polackal M; George IC; Witzel T; Klawiter EC; Huang SY
    Neuroimage Clin; 2020; 27():102293. PubMed ID: 32563921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.